Opportunity (& Turbulence) In Digital Therapeutics

Digital treatment options have seen a big increase in acceptance since the beginning of the pandemic. The reasons are apparent. Digital therapeutics (DTx) offer a wide range of benefits for consumers, for provider organization, and for health plans—like ease of access, shorter development timelines, versatile delivery platforms, decreased cost of treatment, personalized treatment options, enhanced medication adherence, and promotion of healthy lifestyles. Those benefits are why the DTx market is expected to grow at a compounded annual growth rate of nearly 20% between 2022 and 2035—with an estimated market value of over $20 billion (see Digital Therapeutics Market . . .